New Interventions for Critical Limb Ischemia

article image

Critical limb ischemia is the worst kind of peripheral artery disease, and it comes with a poor prognosis: 50% of CLI patients will eventually undergo an amputation and 25% will die within one year of diagnosis. It’s also the final frontier in vascular medicine—a diagnosis that lacks adequate definition, rigorous clinical trials, standardized treatment protocols, and even its own purpose-built interventional tools.

Peripheral artery disease (PAD), or atherosclerosis in arteries in the limbs, is on the rise worldwide, driven by rapidly aging populations and a combination of well-known risk factors, including diabetes, smoking, high cholesterol, kidney disease, obesity, and a sedentary lifestyle.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: